PDT Partners, LLC - TETRAPHASE PHARMACEUTICALS I ownership

Back to all holdings Add to watchlist

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 96 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2014. The put-call ratio across all filers is 1.37 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
PDT Partners, LLC ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q2 2017$1,369,000
-5.3%
191,952
+22.0%
0.06%
-27.6%
Q1 2017$1,445,000
+42.2%
157,287
+514.5%
0.08%
-24.8%
Q4 2014$1,016,000–25,598–0.10%–
 Download
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q4 2014
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
HUNTINGTON NATIONAL BANK 1$00.00%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders